Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam 0 26.08.2024 07:25 Business Standard Alembic Pharmaceuticals jumped 2.25% to Rs 1,125.35 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
